Description
HEPLOFIT is a combination hepatoprotective and digestive enzyme tablet used to support liver function and improve digestion. It is commonly prescribed for acute and chronic liver disorders and as an adjunct in hepatotoxic drug regimens.
How HEPLOFIT Works
-
L-Ornithine L-Aspartate: Supplies amino acids that help lower toxic ammonia levels in the blood, promote urea formation, and assist in liver cell regeneration—especially valuable in managing hepatitis, cirrhosis, and hepatic encephalopathy.
-
Pancreatin: A mixture of digestive enzymes that improve the breakdown and absorption of dietary proteins, fats, and carbohydrates, helping relieve indigestion, bloating, and discomfort, especially in cases of pancreatic insufficiency or chronic digestive problems.
Uses
-
Support in acute and chronic hepatitis, cirrhosis, and fatty liver disease
-
Adjuvant for patients taking hepatotoxic medications
-
Relief of symptoms related to indigestion, bloating, and pancreatic enzyme deficiency.
-
Control of hepatic encephalopathy by reducing ammonia levels
Benefits
-
Promotes liver detoxification and regeneration
-
Improves nutrient absorption and digestion
-
Reduces bloating, gas, and abdominal discomfort
-
Can be part of comprehensive therapy in liver and digestive disorders.
Common Side Effects
-
Nausea, stomach pain, bloating, diarrhea, constipation.
-
Rare: Headache, dizziness, allergic reactions, or severe abdominal pain—seek medical advice if these occur.
Directions & Precautions
-
Take as prescribed, preferably with meals, and follow physician instructions
-
Not recommended in severe kidney disease or pancreatic inflammation unless approved by a doctor
-
Inform your physician of all concurrent medications and any liver or kidney conditions.
-
Safe for most adults when used as directed; use in pregnancy or breastfeeding only under medical advice
HEPLOFIT is a prescription-only tablet for liver support and digestive enzyme supplementation, not banned in India and available widely for clinical indications.







Leave a Reply